Radiation Dose-Effect Relation in Patients with Esophageal Squamous Cell Carcinoma: A National Cancer Center Data and Literature-Based Analysis

por Han, Weiming, Li, Chen, Deng, Wei, Ni, Wenjie, Chang, Xiao, Gao, Linrui, Wang, Shijia, Wang, Xin, Xiao, Zefen
Publicado 2022

Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol

por Chang, Xiao, Deng, Lei, Ni, Wenjie, Li, Chen, Han, Weiming, Gao, Lin-rui, Wang, Shijia, Zhou, Zongmei, Chen, Dongfu, Feng, Qinfu, Liang, Jun, Bi, Nan, Lv, Jima, Gao, Shugeng, Mao, Yousheng, Xue, Qi, Xiao, Zefen
Publicado 2020

Definitive Simultaneous Integrated Boost Versus Conventional-Fractionated Intensity Modulated Radiotherapy for Patients With Advanced Esophageal Squamous Cell Carcinoma: A Propensi...

por Li, Chen, Tan, Lijun, Liu, Xiao, Wang, Xin, Zhou, Zongmei, Chen, Dongfu, Feng, Qinfu, Liang, Jun, Lv, Jima, Wang, Xiaozhen, Bi, Nan, Deng, Lei, Wang, Wenqing, Zhang, Tao, Ni, Wenjie, Chang, Xiao, Han, Weiming, Xiao, Zefen
Publicado 2021

Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma

por Han, Weiming, Chang, Xiao, Zhang, Wencheng, Yang, Jingsong, Yu, Shufei, Deng, Wei, Ni, Wenjie, Zhou, Zongmei, Chen, Dongfu, Feng, Qinfu, Liang, Jun, Hui, Zhouguang, Wang, Lvhua, Gao, Shugeng, Lin, Yu, Chen, Xiaohui, Chen, Junqiang, Xiao, Zefen
Publicado 2022

Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a prope...

por Li, Chen, Tan, Lijun, Liu, Xiao, Wang, Xin, Zhou, Zongmei, Chen, Dongfu, Feng, Qinfu, Liang, Jun, Lv, Jima, Wang, Xiaozhen, Bi, Nan, Deng, Lei, Wang, Wenqing, Zhang, Tao, Ni, Wenjie, Chang, Xiao, Han, Weiming, Gao, Linrui, Wang, Shijia, Xiao, Zefen
Publicado 2021

A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients...

por Gao, Lin-rui, Wang, Xin, Han, Weiming, Deng, Wei, Li, Chen, Wang, Xiaomin, Zhao, Yidian, Ni, Wenjie, Chang, Xiao, Zhou, Zongmei, Deng, Lei, Wang, Wenqing, Liu, Wenyang, Liang, Jun, Zhang, Tao, Bi, Nan, Wang, Jianyang, Zhai, Yirui, Feng, Qinfu, Lv, Jima, Li, Ling, Xiao, Zefen
Publicado 2020

Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy

por Gao, Lin-Rui, Li, Chen, Han, Weiming, Ni, Wenjie, Deng, Wei, Tan, Lijun, Zhou, Zongmei, Chen, Dongfu, Feng, Qinfu, Liang, Jun, Lv, Jima, Wang, Wenqing, Liu, Wenyang, Deng, Lei, Wang, Xin, Zhang, Tao, Wang, Jianyang, Zhai, Yirui, Bi, Nan, Wang, Lvhua, Hui, Zhouguang, Li, Ye-Xiong, Xiao, Zefen
Publicado 2022

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma

por Han, Weiming, Deng, Wei, Wang, Qifeng, Ni, Wenjie, Li, Chen, Zhou, Zongmei, Liang, Jun, Chen, Dongfu, Feng, Qinfu, Bi, Nan, Zhang, Tao, Wang, Xin, Deng, Lei, Wang, Wenqing, Liu, Wenyang, Wang, Jianyang, Xue, Qi, Mao, Yousheng, Liu, Xiangyang, Fang, Dekang, Li, Jian, Wang, Dali, Zhao, Jun, Xiao, Zefen
Publicado 2022

Dose escalation of 3D radiotherapy is effective for esophageal squamous cell carcinoma: a multicenter retrospective analysis (3JECROG R-03)

por Zhang, Wencheng, Zhao, Jingjing, Han, Weiming, Zhang, Hualei, Wang, Xin, Li, Chen, Chen, Junqiang, Wang, Xiaomin, Zhao, Yidian, Qiao, Xueying, Zhou, Zhiguo, Han, Chun, Zhu, Shuchai, Shen, Wenbin, Wang, Lan, Ge, Xiaolin, Sun, Xinchen, Zhang, Kaixian, Hu, Miaomiao, Li, Ling, Hao, Chongli, Li, Gaofeng, Xu, Yonggang, Wang, Yadi, Lu, Na, Liu, Miaoling, Qian, Shuai, Xiao, Zefen, Wang, Ping, Pang, Qingsong
Publicado 2020

Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis

por Han, Weiming, Wang, Lan, Li, Chen, Chen, Junqiang, Zhang, Wencheng, Wang, Xin, Pang, Qingsong, Zhao, Yidian, Sun, Xinchen, Zhang, Kaixian, Li, Gaofeng, Li, Ling, Qiao, Xueying, Liu, Miaoling, Wang, Yadi, Deng, Lei, Wang, Wenqing, Bi, Nan, Zhang, Tao, Deng, Wei, Ni, Wenjie, Chang, Xiao, Zhou, Zongmei, Liang, Jun, Feng, Qinfu, Wang, Lvhua, Chen, Dongfu, Lv, Jima, Zhu, Shuchai, Han, Chun, Xiao, Zefen
Publicado 2022

S-1–Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II Trial

por Wang, Xin, Ge, Xiaolin, Wang, Xiaomin, Zhang, Wencheng, Zhou, Haiwen, Lin, Yu, Qie, Shuai, Hu, Miaomiao, Wang, Wei, Liu, Ke, Pang, Qingsong, Li, Minghe, Chen, Junqiang, Liu, Miaoling, Zhang, Kaixian, Li, Ling, Shi, Yonggang, Deng, Wei, Li, Chen, Ni, Wenjie, Chang, Xiao, Han, Weiming, Deng, Lei, Wang, Wenqing, Liang, Jun, Bi, Nan, Zhang, Tao, Liu, Wenyang, Wang, Jianyang, Zhai, Yirui, Feng, Qinfu, Chen, Dongfu, Zhou, Zongmei, Zhao, Yidian, Sun, Xinchen, Xiao, Zefen
Publicado 2020

Effectiveness of S-1–Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial

por Wang, Xin, Han, Weiming, Zhang, Wencheng, Wang, Xiaomin, Ge, Xiaolin, Lin, Yu, Zhou, Haiwen, Hu, Miaomiao, Wang, Wei, Liu, Ke, Lu, Jianchao, Qie, Shuai, Zhang, Jihong, Deng, Wei, Wang, Lan, Han, Chun, Li, Minghe, Zhang, Kaixian, Li, Ling, Wang, Qifeng, Shi, Hongyun, Yu, Zhilong, Zhao, Yidian, Sun, Xinchen, Shi, Yonggang, Pang, Qingsong, Zhou, Zongmei, Liang, Jun, Chen, Dongfu, Feng, Qinfu, Bi, Nan, Zhang, Tao, Deng, Lei, Wang, Wenqing, Liu, Wenyang, Wang, Jianyang, Zhai, Yirui, Wang, Junjie, Chen, Wanqing, Chen, Junqiang, Xiao, Zefen
Publicado 2023